Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
STLN (Starling Oncology, Inc.) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Starling Oncology, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Services
Prev close 6.37 · gapped above the open, then crossed back over prior close. High/low 6.55 at 6:00 am ET, 6.33 at 3:30 pm ET.
120 institutional managers report a position in Starling Oncology, Inc. worth $233.3M between them, filed on form 13F for the quarter ending 2026-06-30. 20 of them hold 80% of it, the largest being BlackRock, Inc. at 11.05%.
95 more managers in the register
20 managers hold 80% of the $233.3M institutional base. The other 100 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Deerfield Management Co, Josh Arnold Investment Consultant, LLC, Wexford Capital LP +16 more · 7.82% of STLN, 7.82% of TOI
via Deerfield Management Co, Marshall Wace LLP · 7.82% of STLN, 36.86% of LRMR
via Wexford Capital LP, Marshall Wace LLP, Acadian Asset Management LLC +1 more · 3.98% of STLN, 9.98% of XGN
via Deerfield Management Co, Arrowstreet Capital, Limited Partnership · 7.82% of STLN, 8.04% of AHCO
via Deerfield Management Co, Marshall Wace LLP · 7.82% of STLN, 6.24% of SVRA
via Deerfield Management Co, Arrowstreet Capital, Limited Partnership, CenterBook Partners LP · 7.82% of STLN, 7.83% of LEGN
Managers holding a meaningful stake in STLN also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.